A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2017; you can also visit the original URL.
The file type is application/pdf
.
Relationship Between Intravenous Busulfan Pharmacokinetics and Patient Characteristics in Allogeneic Stem Cell Transplant
2014
Biology of Blood and Marrow Transplantation
we implemented a simpler technique for administration of melphalan by preparing all doses in a total volume of 250 mL NS. This method yields concentrations between 0.45 to 2 mg/mL for patients of a BSA from 0.81 to 3.56 m 2 for 140 mg/m 2 doses and 0.57 to 2.5 m 2 for 200 mg/ m 2 doses. In a review of the first 30 autologous HCT patients who received melphalan 200 mg/m 2 via this method, median engraftment was on days 12 and 16 for neutrophils and platelets, respectfully, which is the same as
doi:10.1016/j.bbmt.2013.12.493
fatcat:3pdnz4tkqfegrh7uskzfp6njb4